-
Molecular therapyVrsta gradiva - časopisIzdaja - [Print ed.]Založništvo in izdelava - San Diego (CA) : Academic Press, 2000-Jezik - angleškiISSN - 1525-0016COBISS.SI-ID - 1481749
Povezava(-e):
http://www.cell.com/molecular-therapy-family/molecular-therapy/archiveDostop za OILJ, omejen z geslom
http://www.sciencedirect.com/science/journal/15250016
SHERPA/RoMEORevija v inf. servisu SHERPA/RoMEO - politike založnikov za objavljanje in arhiviranje v odprtem dostopu
SHERPA/RoMEO Journal - Publisher copyright policies & self-archiving (open access)
ScienceDirect (Elsevier)Celotno besedilo dostopno za uporabnike CTK, NUK, UL, UM, UP, UNG, IJS, KI, ZRC SAZU, GEOZS, OILJ, SBCE, UKCMB, SBJE, UPKLJ, IMT, KIS od 2000
Full text accessible to the users of CTK, NUK, UL, UM, UP, UNG, IJS, KI, ZRC SAZU, GEOZS, OILJ, SBCE, UKCMB, SBJE, UPKLJ, IMT, KIS from 2000 http://www.sciencedirect.com/
Knjižnica/institucija |
Kraj | Akronim | Leto | Za izposojo | Druga zaloga |
---|---|---|---|---|---|
Onkološki inštitut Ljubljana | Ljubljana | OILJ | redni dotok 2011- |
v čitalnico 10 letn.
|
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva Molecular therapy
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP | |
2021 | 1.966 |
SE
SE
SE
SE
SE
|
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
Molecular Biology
|
8/156
14/170
13/309
25/332
42/393
|
||||
2022 | 1.720 |
SE
SE
SE
SE
SE
|
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
|
46/391
8/157
15/171
19/303
28/332
|
||||
2020 | 1.848 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
18/304
33/330
41/392
7/156
15/165
|
||||
2019 | 1.535 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
31/310
42/328
52/386
14/163
18/168
|
||||
2018 | 1.428 |
SE
SE
SE
SE
SE
|
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
|
48/325
61/384
16/168
19/168
35/307
|
||||
2010 | 1.374 |
SE
SE
SE
SE
SE
|
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
|
52/320
17/142
20/144
33/308
43/264
|
||||
2012 | 1.511 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
30/316
38/287
54/346
16/167
17/153
|
||||
2017 | 1.338 |
SE
SE
SE
SE
SE
|
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
|
52/319
67/376
19/165
26/165
37/304
|
||||
2015 | 1.413 |
SE
SE
SE
SE
SE
|
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
Molecular Biology
|
14/168
16/163
32/305
44/302
57/364
|
||||
2011 | 1.475 |
SE
SE
SE
SE
SE
|
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
|
41/278
50/336
15/161
21/151
32/323
|
||||
2016 | 1.401 |
SE
SE
SE
SE
SE
|
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
|
61/369
20/168
20/161
33/302
46/308
|
||||
2013 | 1.418 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
38/319
44/290
60/348
19/170
25/155
|
||||
2002 | 1.252 |
SE
SE
SE
SE
SE
|
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
Molecular Biology
|
12/81
20/81
28/239
39/191
45/230
|
||||
2009 | 1.294 |
SE
SE
SE
SE
SE
|
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
Molecular Biology
|
16/127
24/134
39/285
47/247
64/309
|
||||
2014 | 1.386 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
37/311
49/295
62/355
17/165
21/159
|
||||
2003 | 1.180 |
SE
SE
SE
SE
SE
|
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
Genetics
|
58/233
19/86
24/90
36/247
45/195
|
||||
2008 | 1.234 |
SE
SE
SE
SE
SE
|
Molecular Medicine
Pharmacology
Genetics
Molecular Biology
Drug Discovery
|
24/129
36/272
46/234
60/294
16/120
|
||||
2007 | 1.314 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
36/264
42/217
50/279
18/118
22/128
|
||||
2006 | 1.222 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
38/260
46/208
62/264
16/104
19/113
|
||||
2001 | 0.836 |
SE
SE
SE
SE
SE
|
Pharmacology
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
|
55/214
87/177
99/212
23/73
36/75
|
||||
2005 | 1.120 |
SE
SE
SE
SE
SE
|
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
|
60/200
75/247
21/98
28/104
50/259
|
||||
2004 | 1.058 |
SE
SE
SE
SE
SE
|
Genetics
Molecular Biology
Drug Discovery
Molecular Medicine
Pharmacology
|
66/198
81/239
17/89
30/94
49/248
|
||||
2000 |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|---|---|
Medline | za medicino in stomatologijo | do 2023 |
Biological Abstracts | za biologijo | 2016 - 2023 |
CAPlus (Chemical Abstracts Plus) | za kemijo | do 2013 |
BIOSIS Previews | za biologijo | 2014 - 2023 |
Scopus | za naravoslovne vede | do 2023 |
Science Citation Index Expanded (SCI-EXPANDED) | za naravoslovne vede | do 2023 |
PubMed | za medicino in stomatologijo | do 2023 |
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.